Plazza Seeks $15 Million Investment from Accel, Elevation, Nexus

Plazza Aims to Expand Store Network with $15 Million Funding Round

Quick medicine delivery startup Plazza is in advanced talks to raise around $15 million in a new funding round, as it looks to expand its store network and double down on hyperlocal fulfilment. According to sources, the round is expected to see $4 million each from Accel, Elevation Capital, and Nexus Venture Partners, with the remaining $3 million coming from existing backers, including All In Capital.

The fundraise is likely to value the Bengaluru-based startup at around $50 million, cautioning that terms of the deal are yet to be finalised. This latest round will come just months after Plazza raised $1.4 million in a seed funding round led by All In Capital, with participation from Better Capital and several angel investors.

| Funding Round | Funding Amount | Investors | | --- | --- | --- | | Seed Round | $1.4 million | All In Capital, Better Capital, and several angel investors | | Current Round | $15 million | Accel, Elevation Capital, Nexus Venture Partners, and existing backers |

The rapid follow-on raise signals strong early traction as well as capital intensity in the model, which relies on owning inventory and running hyperlocal fulfilment infrastructure. Queries sent to Accel, Elevation Capital, Nexus Venture Partners, and All In Capital did not elicit a response.

Hyperlocal Fulfilment and Rapid Growth

Founded as a quick medicine delivery platform, Plazza promises deliveries within 15 to 60 minutes, positioning itself closer to a quick commerce model for pharmaceuticals rather than a traditional e-pharmacy marketplace. The startup operates an inventory-led model, stocking a wide range of medicines and healthcare products in its stores, which function similarly to dark stores used by grocery delivery platforms.

According to details shared earlier, Plazza offers over 20,000 SKUs, significantly higher than a typical neighbourhood pharmacy and has served over 10,000 customers, with weekly growth pegged at around 25 percent. The company is also planning to open around 20 outlets over the next 12 months.

Competitive Landscape

Plazza's scale-up plans come amid a broader push by quick commerce and e-pharmacy players to tap into on-demand medicine delivery, a category that is still evolving but increasingly competitive. Platforms such as Swiggy Instamart have partnered with PharmEasy to offer medicines, while players like Zepto have been exploring direct offerings. Amazon India has also expanded its healthcare stack through diagnostics and pharmacy integrations.

While the opportunity in instant medicine delivery is large, it is also operationally and financially intensive, given the need for store expansion, inventory management, and regulatory compliance. The planned $15-million raise is expected to help Plazza scale its store footprint, deepen inventory, and invest in supply-chain capabilities, as it looks to compete with larger, better-funded incumbents entering the space.